synbiology
Providing up to date news, answering questions and gathering opinions about Synthetic Biology.
CRISPR and Recent Research Advances in Genome Engineering
CRISPR and Recent Research Advances in Genome Engineering
By Kevin Holden, PhD, Head of Synthetic Biology at Synthego
This is the fourth part in the CRISPR...
CRISPR Research Developments in 2017
CRISPR 101: Research Developments in 2017
By Kevin Holden, PhD, Head of Synthetic Biology at Synthego
This is the third part in the CRISPR 101 series...
CRISPR 101: Applications and Future Potential
CRISPR 101: Applications and Future Potential
By Kevin Holden, PhD, Head of Synthetic Biology at Synthego
This is the second part in the CRISPR 101 series...
146 Synthetic Biology Companies and Investors
No longer a confusing amalgam of disciplines, synthetic biology is at the forefront of biotech. In the last decade, the span and expectation of...
CRISPR 101: What is CRISPR-Cas9?
CRISPR 101: What is CRISPR-Cas9?
By Kevin Holden, PhD, Head of Synthetic Biology at Synthego
This is the first part in the CRISPR 101 series by...
Arzeda raises $12m to accelerate scale up
Seattle-based Arzeda, a synthetic biology company with roots at the University of Washington, announced it has raised $12 million in a Series A fundraising...
